TRIMETHOPRIM-SULFAMETHOXAZOLE VS STANDARD/CLASSIC TREATMENT OF OCULAR TOXOPLASMOSIS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

SADOUGHI M.M.; SOHEYLIAN MASOUD; DEHGHAN FIROUZABADI M.H.; BEHBOUDI H.; SEMNANI M.A.; ANISIAN A.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: BINA Year:2003 | Volume:8 | Issue:4 (32) Page(s): 303-310

Download Full-Text

Persian Verion

View:

6,818

Download:

Cites:

Information Journal Paper

Title

TRIMETHOPRIM-SULFAMETHOXAZOLE VS STANDARD/CLASSIC TREATMENT OF OCULAR TOXOPLASMOSIS

Author(s)

Keywords

OCULAR TOXOPLASMOSISQ3

TRIMETHOPRIM- SULFAMETHOXAZOLEQ3

STANDARD/CLASSIC TREATMENTQ3

Abstract

Purpose: To compare the efficacy of the standard treatment of OCULAR TOXOPLASMOSIS (pyrimethamine, sulfadiazine, and predinsolone) with a regimen consisting of trimethoprim sulfamethoxazole (TMP/SMX) plus predinsolone.Methods: In a prospective randomized single-blind clinical trial, 59 patients were randomly assigned to treatment groups: 29 in the pyrimethamine/ sulfadiazine group and 30 patients to the TMP/SMX group. Treatment consisted of six weeks of antibiotics plus steroids, and patients were followed weekly with measurements of visual acuity and examination of the anterior vitreous and fundus for signs of inflammation ELISA measurements of anti- toxoplasmosis antibodies (IgM and IgG) were undertaken. The main outcome measure consisted of change in size of the retinochoroidal lesion on fundus photography, obtained at initiation and completion of treatment.Results: No significant difference was found in the amount of decrease in retinochoroidal lesion between the two treatment groups (61% reduction in the classic treatment group ND 59% in the TMP/SMX regimen, P = 0.69). Similarly no significant difference was found in visual acuity after treatment between the two groups (mean visual acuity after treatment 0.11 Log MAR in both groups, P = 0.41). Adverse treatment effects were similar in both groups, with one patient in each suffering from any significant drug side effects. The rate of recurrence with an average of 14 months follow up was 6.8% with no significant difference between treatment groups (P = 0.48). Conclusions: The efficacy in terms of decrease in retinal lesion and improvement in visual acuity was similar between a regimen of TMP/SMX plus steroid and the standard treatment of OCULAR TOXOPLASMOSIS with pyrimethamine and sulfadiazine plus steroids. Therapy with TMP/SMX appears to be an acceptable alternative for the treatment of OCULAR TOXOPLASMOSIS. A prospective randomized clinical trial, which would match patients in terms of size of retinal lesions, is recommended for stronger conclusion.

Cites

SHORT-TERM VS LONG-TERM SYSTEMIC CORTICOSTEROID IN OCULAR TOXOPLASMOSIS

References

Cite

APA: Copy

SADOUGHI, M.M., SOHEYLIAN, MASOUD, DEHGHAN FIROUZABADI, M.H., BEHBOUDI, H., SEMNANI, M.A., & ANISIAN, A.. (2003). TRIMETHOPRIM-SULFAMETHOXAZOLE VS STANDARD/CLASSIC TREATMENT OF OCULAR TOXOPLASMOSIS. BINA, 8(4 (32)), 303-310. SID. https://sid.ir/paper/42554/en

Vancouver: Copy

SADOUGHI M.M., SOHEYLIAN MASOUD, DEHGHAN FIROUZABADI M.H., BEHBOUDI H., SEMNANI M.A., ANISIAN A.. TRIMETHOPRIM-SULFAMETHOXAZOLE VS STANDARD/CLASSIC TREATMENT OF OCULAR TOXOPLASMOSIS. BINA[Internet]. 2003;8(4 (32)):303-310. Available from: https://sid.ir/paper/42554/en

IEEE: Copy

M.M. SADOUGHI, MASOUD SOHEYLIAN, M.H. DEHGHAN FIROUZABADI, H. BEHBOUDI, M.A. SEMNANI, and A. ANISIAN, “TRIMETHOPRIM-SULFAMETHOXAZOLE VS STANDARD/CLASSIC TREATMENT OF OCULAR TOXOPLASMOSIS,” BINA, vol. 8, no. 4 (32), pp. 303–310, 2003, [Online]. Available: https://sid.ir/paper/42554/en

Related Journal Papers